The recall potentially affects more than 1 million people. It is the second time the FDA has found sterility issues at the company in three years.
Articles on Drug recalls
Displaying all articles
As the generics market for a particular drug gets crowded, competition on price might be driving quality issues that could harm patients.
This recall affects America’s most prescribed drug. It’s the latest in a series of concerning manufacturing issues that have come to light over the past few years.
When drugs are taken off the market because they are either unsafe or don’t work, do pharma companies admit that there are problems? Or do they deny the evidence?
COVID-19 has exacerbated a backlog of domestic and foreign drug manufacturing inspections that the FDA is still too short-staffed to adequately deal with.
Top contributors
-
Distinguished Professor of Pharmacy Practice, University of Connecticut
-
Associate professor, Department of Family and Community Medicine, University of Toronto; York University, Canada; University of Sydney
-
Associate Professor of Comparative Effectiveness and Outcomes Research, University of Connecticut